These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 12695884)

  • 21. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 13C enrichment of extracellular neurotransmitter glutamate in rat brain--combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo.
    Kanamori K; Kondrat RW; Ross BD
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):819-36. PubMed ID: 14528919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy.
    Sinha S; Ekka M; Sharma U; P R; Pandey RM; Jagannathan NR
    BMC Res Notes; 2014 Jan; 7():41. PubMed ID: 24433580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
    Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
    Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain.
    Gussew A; Rzanny R; Güllmar D; Scholle HC; Reichenbach JR
    Neuroimage; 2011 Jan; 54(2):1315-23. PubMed ID: 20869447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
    Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
    Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease.
    Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2002 Jan; 13(1):183-6. PubMed ID: 11924885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
    Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
    Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
    Mohamed MA; Barker PB; Skolasky RL; Selnes OA; Moxley RT; Pomper MG; Sacktor NC
    Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
    Penner J; Rupsingh R; Smith M; Wells JL; Borrie MJ; Bartha R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):104-10. PubMed ID: 19833161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.
    Keshavan MS; Dick RM; Diwadkar VA; Montrose DM; Prasad KM; Stanley JA
    Schizophr Res; 2009 Nov; 115(1):88-93. PubMed ID: 19748228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
    Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
    Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z; Liu X; Cao Y; Hou H; Chen X; Chen Y; Huang F; Chen W
    Altern Ther Health Med; 2017 May; 23(3):12-18. PubMed ID: 28236618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Jahng GH; Oh J; Lee DW; Kim HG; Rhee HY; Shin W; Paik JW; Lee KM; Park S; Choe BY; Ryu CW
    J Alzheimers Dis; 2016 Mar; 52(1):145-59. PubMed ID: 27060946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricarboxylic acid cycle activity measured by 13C magnetic resonance spectroscopy in rats subjected to the kaolin model of obstructed hydrocephalus.
    Melø TM; Håberg AK; Risa Ø; Kondziella D; Henry PG; Sonnewald U
    Neurochem Res; 2011 Oct; 36(10):1801-8. PubMed ID: 21603937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo
    Lai M; Lanz B; Poitry-Yamate C; Romero JF; Berset CM; Cudalbu C; Gruetter R
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1701-1714. PubMed ID: 29047296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.